Results 41 to 50 of about 4,893,948 (292)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
Adverse events during therapeutic plasma exchange (n = 466 single sessions).
, 2015 ICU = intensive care unit, Moderate hypotension = systolic blood pressure below 95 mmHg, No. = number.Adverse events during therapeutic plasma exchange (n = 466 single sessions).
Sebastian Koball (780147) +6 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng +3 more
wiley +1 more source
Therapeutic Plasma Exchange—A Practical Guide
Kidney and DialysisTherapeutic plasma exchange is a procedure in which plasma is removed and replaced with another fluid to correct blood abnormalities. There is growing evidence of its benefit in certain clinical conditions, including thrombotic thrombocytopenic purpura ...
Mariana Dias Pais +2 more
doaj +1 more source
Degradation mechanism of the von Willebrand factor A2 domain by nattokinase
FEBS Letters, EarlyView.Nattokinase, a natto‐derived protease, exhibits potent antithrombotic effects. This study demonstrates that nattokinase directly cleaves the von Willebrand factor (vWF) A2 domain in vitro. Unlike the native regulator ADAMTS13, nattokinase degrades folded vWF independently of shear stress.
Ryuichi Hyakumoto +3 more
wiley +1 more source
Therapeutic Plasma Exchange in Refractory Hyperthyroidism [PDF]
European Thyroid Journal, 2020 Abstract Introduction: Hyperthyroid patients who are unresponsive to medical treatment remain a challenging clinical problem. Objective: The goal of our study was to evaluate the use of therapeutic plasma exchange (TPE) in hyperthyroid patients and their outcome after TPE.
Clotilde, Saïe +9 more
openaire +2 more sources
Therapeutic Plasma Exchange in a Patient with Hemophagocytic Lymphohistiocytosis [PDF]
, 2019 A 22-year old female patient with systemic lupus erythematosus presenting microangiopathic hemolytic anemia was treated with therapeutic plasma exchange 23 times.
이경애 +3 more
core +1 more source
FEBS Letters, EarlyView.CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens +8 more
wiley +1 more source
Nurses' Performance Regarding Patients Undergoing Therapeutic Plasma Exchange [PDF]
Egyptian Journal of Health CareBackground: Therapeutic plasma exchange is a procedure which removes plasma that contains circulating pathogenic substances, such as auto reactive antibodies, immune complexes, paraproteins, lipoproteins, inflammatory mediators like cytokines and return ...
Hanan Shehata Mohamed +3 more
doaj +1 more source
Therapeutic plasma exchange in clinically isolated syndrome and multiple sclerosis patients.
, 2015 CIS = clinically isolated syndrome, EDSS = expanded disability status scale, MS = multiple sclerosis, No. = number, PP-MS = primary progressive MS with acute worsening, RR-MS = relapsing-remitting MS, SP-MS = secondary progressive MS with superimposed ...
Sebastian Koball (780147) +6 more
core +1 more source